Walleye Trading LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,205,717
+13.5%
336,504
+15.3%
0.01%0.0%
Q2 2023$4,585,749
+4.0%
291,900
+9.1%
0.01%
+30.0%
Q1 2023$4,410,048
+51.1%
267,600
+43.0%
0.01%
+25.0%
Q4 2022$2,918,760
-16.2%
187,100
-30.3%
0.01%
-20.0%
Q3 2022$3,481,000
+210.8%
268,400
+236.3%
0.01%
+233.3%
Q2 2022$1,120,000
+40.4%
79,800
+43.3%
0.00%0.0%
Q1 2022$798,000
-58.7%
55,700
-60.7%
0.00%
-50.0%
Q4 2021$1,932,000
-20.4%
141,700
-4.3%
0.01%
-25.0%
Q3 2021$2,426,000
-10.9%
148,100
-8.5%
0.01%
-27.3%
Q2 2021$2,723,000
-16.7%
161,800
-9.7%
0.01%
-26.7%
Q1 2021$3,270,000
+128.7%
179,100
+127.9%
0.02%
+114.3%
Q4 2020$1,430,000
-96.6%
78,600
-96.4%
0.01%
-97.6%
Q4 2019$42,519,000
+32.4%
2,155,055
+15.4%
0.29%
+7.3%
Q3 2019$32,118,000
-35.1%
1,867,356
-33.2%
0.27%
-36.0%
Q2 2019$49,503,000
-19.1%
2,796,730
-6.9%
0.43%
-9.9%
Q1 2019$61,172,0003,003,0570.48%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders